Efficient gene delivery to myocardium with ultrasound targeted microbubble destruction and polyethylenimine

Abstract

The aim of present study was to evaluate the feasibility and efficiency of enhanced green fluorescent protein (EGFP) gene delivery to myocardium in vivo by ultrasound targeted microbubble destruction (UTMD) and polyethylenimine (PEI). SonoVue/DNA and PEI/DNA/SonoVue complexes were prepared. Gel electrophoresis analysis was performed to determine the structural integrity of plasmid DNA or PEI/DNA after UTMD. Solutions of plasmid DNA, SonoVue/DNA, PEI/DNA complexes or PEI/DNA/SonoVue complexes were respectively transduced into BALB/c mice hearts by means of transthoracic ultrasound irradiation. Mice undergoing PBS injection, plasmid injection or PEI/DNA complexes injection without ultrasound irradiation served as controls. Gene expression in myocardium was detected 4 days after treatment. Cryosections and histological examinations were conducted. Electrophoresis gel assay showed no damage to DNA or PEI/DNA complexes after UTMD. When the heart was not exposed to ultrasound, the expression of EGFP was observed in the subendocardial myocardium obviously. The strongest expression was detected in the anterior wall of the left ventricle when the heart was exposed to ultrasound alone. Injection of PEI/DNA complexes and UTMD resulted in the highest transfection efficiency and the distributional difference of EGFP was not obvious. No tissue damage was seen histologically. In conclusion, a combination of UTMD and PEI was highly effective in transfecting mice hearts without causing any apparently adverse effect. It provides an alternative to current clinical gene therapy and opens a new concept of non-viral gene delivery for the treatment of cardiac disease.

Keywords

ultrasound / polyethylenimine / gene delivery / microbubble / myocardium

References

[1] BekeredjianR., ChenS., PanW., et al.. Effects of ultrasound-targeted microbubble destruction on cardiac gene expression. Ultrasound Med Biol, 2004, 30: 539-543

[2] ChenS., ShohetR. V., BekeredjianR., et al.. Optimization of ultrasound parameters for cardiac gene delivery of adenoviral or plasmid deoxyribonucleic acid by ultrasound targeted microbubble destruction. J Am Coll Cardiol, 2003, 42: 301-308

[3] LiX., WangZ., RanH., et al.. Experimental research on therapeutic angiogenesis induced by hepatocyte growth factor directed by ultrasound-targeted microbubble destruction in rats. J Ultrasound Med, 2008, 27: 453-460

[4] MüllerO. J., KatusH. A., BekeredjianR.. Targeting the heart with gene therapy-optimized gene delivery methods. Cardiovasc Res, 2007, 73: 453-462

[5] ZenK., OkigakiM., HosokawaY., et al.. Myocardium-targeted delivery of endothelial progenitor cells by ultrasound-mediated microbubble destruction improves cardiac function via an angiogenic response. J Mol Cell Cardiol, 2006, 40: 799-809

[6] DeshpandeM. C., PrausnitzM. R.. Synergistic effect of ultrasound and PEI on DNA transfection in vitro. J Control Release, 2007, 118: 126-135

[7] LeeY. H., PengC. A.. Nonviral transfection of suspension cells in ultrasound standing wave fields. Ultrasound Med Biol, 2007, 33: 734-742

[8] ChumakovaO. V., LiopoA. V., AndreevV. G., et al.. Composition of PLGA and PEI/DNA nanoparticles improves ultrasound-mediated gene delivery in solid tumors in vivo. Cancer Lett, 2008, 261: 215-225

[9] WangG., HuS., ZhengZ., et al.. Synthesis of new gene-loaded microbubbles serve as gene delivery vehicle applied in reporter gene transfer into cardiac myocytes. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi (Chinese), 2006, 23: 856-861

[10] WeiW., XuC., WuH.. Use of PEI-coated magnetic iron oxide nanoparticles as gene vectors. J Huazhong Univ Sci Technolog Med Sci, 2004, 24: 618-620

[11] PanH., ZhengQ., GuoX., et al.. A RGD-containing oligopeptide (K)₁₆GRGDSPC: a novel vector for integrin-mediated targeted gene delivery. J Huazhong Univ Sci Technolog Med Sci, 2006, 26: 513-516

[12] YeL., HaiderH. K. H., TanR., et al.. Transplantation of nanoparticle transfected skeletal myoblasts overexpressing vascular endothelial growth factor-₁₆₅ for cardiac repair. Circulation, 2007, 116: I113-I120

[13] IwasakiM., AdachiY., NishiueT., et al.. Hepatocyte growth factor delivered by ultrasound-mediated destruction of microbubbles induces proliferation of cardiomyocytes and amelioration of left ventricular contractile function in Doxorubicin-induced cardiomyopathy. Stem Cells, 2005, 23: 1589-1597

[14] GuoD. P., LiX. Y., SunP., et al.. Ultrasound/microbubble enhances foreign gene expression in ECV304 cells and murine myocardium. Acta Biochim Biophy Sin, 2004, 36: 824-831

[15] KondoI., OhmoriK., OshitaA., et al.. Treatment of acute myocardial infarction by hepatocyte growth factor gene transfer: the first demonstration of myocardial transfer of a “functional” gene using ultrasonic microbubble destruction. J Am Coll Cardio, 2004, 44: 644-653

[16] KorpantyG., ChenS., ShohetR. V., et al.. Targeting of VEGF-mediated angiogenesis to rat myocardium using ultrasonic destruction of microbubbles. Gene Ther, 2005, 12: 1305-1312

[17] KuoJ. H., JanM. S., SungK. C.. Evaluation of the stability of polymer-based plasmid DNA delivery systems after ultrasound exposure. Int J Pharm, 2003, 257: 75-84

[18] DaileyL. A., KleemannE., MerdanT., et al.. Modified polyethylenimines as non viral gene delivery systems for aerosol therapy: effects of nebulization on cellular uptake and transfection efficiency. J Control Release, 2004, 100: 425-436

[19] LentzY. K., AnchordoquyT. J., LengsfeldC. S.. DNA acts as a nucleation site for transient cavitation in the ultrasonic nebulizer. J Pharm Sci, 2006, 95: 607-619

[20] MalekS., KaplanE., WangJ. F., et al.. Successful implantation of intravenously administered stem cells correlates with severity of inflammation in murine myocarditis. Pflugers Arch, 2006, 452: 268-275

[21] TangX., LiaoY., ChenZ., et al.. Expression of IL-1beta and TNF-alpha in MCMV myocarditis and its role. J Huazhong Univ Sci Technolog Med Sci, 2005, 25: 254-256

[22] UchegbuI. F., SadiqL., PardakhtyA., et al.. Gene transfer with three amphiphilic glycol chitosans-the degree of polymerisation is the main controller of transfection efficiency. J Drug Target, 2004, 12: 527-539